P3 Health Partners Inc
NASDAQ:PIII
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its Industry Average (19.2), the stock would be worth $-63.36 (2 434% downside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -0.8 | $2.72 |
0%
|
| Industry Average | 19.2 | $-63.36 |
-2 434%
|
| Country Average | 19.6 | $-64.59 |
-2 479%
|
Forward EV/EBIT
Today’s price vs future ebit
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
P3 Health Partners Inc
NASDAQ:PIII
|
19.6m USD | -0.8 | -0.1 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
100.2B USD | 14.3 | 56.7 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
68.5B EUR | 9.8 | 13.2 | |
| US |
|
Cigna Corp
NYSE:CI
|
73.7B USD | 0 | 12.4 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
22.9B EUR | 13.8 | 18.1 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.1B EUR | 16.8 | 23.6 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.9B USD | 16.2 | 22.2 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.8B USD | 17.3 | 24.8 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.9B EUR | 9.9 | 11.1 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.5B USD | -27.4 | -27.6 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.6B USD | 9.9 | 14.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 13.6 |
| Median | 19.6 |
| 70th Percentile | 27.8 |
| Max | 1 826 183.2 |
Other Multiples
P3 Health Partners Inc
Glance View
P3 Health Partners, Inc. is a population health care management company. The company is headquartered in Chicago, Illinois and currently employs 450 full-time employees. The company went IPO on 2021-02-10. The firm develops a network of primary care, specialty and ancillary providers managing the care. The company supports providers with administrative services and care coordination for Medicare Advantage patients. The firm navigates, coordinates and integrates care to create a customized care plan for each patient. The firm offers P3 care model that consists of education, tools and support to manage illness, prevention and wellness support, medication management, nursing support, access to community resources and services, and transition of care teams, which combine to form a single approach to patient care. Its technology offers data-backed solutions and care provision, seamless transition of payor and patient data across platforms, real-time data sharing, predictive analytics and risk stratification, and workflows across complex patient panels.
